Amgen Inc. buy UBS Group AG
Start price
06.01.26
/
50%
€283.85
Target price
06.01.27
-
Performance (%)
5.34%
Price
22:25
€296.50
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 5.34%. Dividends of €2.52 are taken into consideration when calculating the performance. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -1.584% | -1.584% |
| iShares Core DAX® | 0.444% | 3.030% |
| iShares Nasdaq 100 | 3.819% | 4.073% |
| iShares Nikkei 225® | 1.148% | 6.904% |
| iShares S&P 500 | 2.371% | 2.677% |
Comments by UBS_Group_AG for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat